PRE-EXPOSURE PROPHYLAXIS OF COVID-19 WITH TIXAGEVIMAB AND CILGAVIMAB IN RHEUMATOLOGIC PATIENTS TREATED WITH RITUXIMAB: DATA FROM A SINGLE-CENTRE COHORT

被引：0
|
作者：
Manara, M. [1 ]
Sette, M. [1 ,2 ]
Giudice, L. [1 ,2 ]
Biggioggero, M. [1 ]
Del Papa, N. [1 ]
Favalli, E. G. [1 ,2 ]
Gerosa, M. [1 ,2 ]
Ingegnoli, F. [1 ,2 ]
Caporali, R. [1 ,2 ]
机构：
[1] ASST G Pini CTO, Dept Rheumatol & Med Sci, Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
COVID; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.4488
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0545
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [1] COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience
    Lee, Kee Tat
    Low, Woei Chyuan
    Tan, Sui Keat
    Chiang, Su Kien
    Chew, Teng Keat
    Goh, Ai Sim
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 167 - 167
  • [2] COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience
    Lee, Kee Tat
    Low, Woei Chyuan
    Tan, Sui Keat
    Chiang, Su Kien
    Chew, Teng Keat
    Goh, Ai Sim
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 167 - 167
  • [3] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1641): : 1 - 2
  • [4] Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19
    Abramowicz, Mark
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 384 - 385
  • [5] PRE-EXPOSURE PROPHYLAXIS WITH TIXAGEVIMAB/ CILGAVIMAB: SINGLE CENTRE EXPERIENCE IN A COHORT OF RHEUMATIC PATIENTS
    Cuzzocrea, F.
    Grieco, G. P.
    Bartoletti, A.
    Delvino, P.
    Esposito, G. L.
    Lilleri, D.
    Girardi, D.
    Cusato, M.
    Calvi, M.
    Marena, C.
    Montecucco, C.
    Codullo, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2036 - 2037
  • [6] Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients
    Fernandez-Prada, Maria
    Perez-Martin, Jaime Jesus
    Cienfuegos-Gonzalez, Paula
    MEDICINA CLINICA, 2023, 160 (10): : 458 - 459
  • [7] Pre-Exposure Prophylaxis and Treatment with Tixagevimab/Cilgavimab for COVID-19 among Immunocompromised Pediatric Patients
    Fraczkiewicz, Jowita
    Pawinska-Wasikowska, Katarzyna
    Szymbor, Katarzyna
    Balwierz, Walentyna
    Skoczen, Szymon
    Czyzewski, Krzysztof
    Koltan, Sylwia
    Styczynski, Jan
    Malecka, Anna
    Irga-Jaworska, Ninela
    Trelinska, Joanna
    Mlynarski, Wojciech
    Zajac-Spychala, Olga
    Sobkowiak-Sobierajska, Agnieszka
    Derwich, Katarzyna
    Bal, Wioletta
    Chaber, Radoslaw
    Ksiazek, Agnieszka
    Szczepanski, Tomasz
    Zawitkowska, Joanna
    Drabko, Katarzyna
    Chodala-Grzywacz, Agnieszka
    Karolczyk, Grazyna
    Kobierzycki, Christopher
    Kalwak, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [8] Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19
    Zhuravleva, Marina, V
    Chulanov, Vladimir P.
    Gagarina, Julia, V
    Shabalina, Elena A.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (01) : 66 - 77
  • [9] Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
    Nguyen, Yann
    Flahault, Adrien
    Chavarot, Nathalie
    Melenotte, Clea
    Cheminant, Morgane
    Deschamps, Paul
    Carlier, Nicolas
    Lafont, Emmanuel
    Thomas, Marion
    Flamarion, Edouard
    Lebeaux, David
    Charlier, Caroline
    Rachline, Anne
    Guerin, Corinne
    Ratiney, Robert
    Touchard, Justine
    Pere, Helene
    Rozenberg, Flore
    Lanternier, Fanny
    Arlet, Jean-Benoit
    Avouac, Jerome
    Boussaud, Veronique
    Guillemain, Romain
    Vignon, Marguerite
    Thervet, Eric
    Scemla, Anne
    Weiss, Laurence
    Mouthon, Luc
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1654.e1 - 1654.e4
  • [10] Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
    Desai, Aakash
    Hashash, Jana G.
    Kochhar, Gursimran S.
    Farraye, Francis A.
    CROHNS & COLITIS 360, 2023, 5 (03)
12345